Corrigendum

Fragment-Based Design of Ligands Targeting a Novel Site on the Integrase Enzyme of Human Immunodeficiency Virus1

J Wielens, S J Headey, J J Deadman, D I Rhodes, M W Parker, D K Chalmers, M J Scanlon

Research output: Contribution to journalComment / DebateOtherpeer-review

Original languageEnglish
Pages (from-to)583
Number of pages1
JournalChemMedChem
Volume6
Issue number4
DOIs
Publication statusPublished - 4 Apr 2011

Keywords

  • Antiviral agents
  • Fragment-based drug design
  • HIV-1 integrase
  • NMR spectroscopy

Cite this

@article{04c3e51d17f64d92a5f2bf1559ec92aa,
title = "Corrigendum: Fragment-Based Design of Ligands Targeting a Novel Site on the Integrase Enzyme of Human Immunodeficiency Virus1",
keywords = "Antiviral agents, Fragment-based drug design, HIV-1 integrase, NMR spectroscopy",
author = "J Wielens and Headey, {S J} and Deadman, {J J} and Rhodes, {D I} and Parker, {M W} and Chalmers, {D K} and Scanlon, {M J}",
year = "2011",
month = "4",
day = "4",
doi = "10.1002/cmdc.201190013",
language = "English",
volume = "6",
pages = "583",
journal = "ChemMedChem",
issn = "1860-7179",
publisher = "Wiley-VCH Verlag GmbH & Co. KGaA",
number = "4",

}

Corrigendum : Fragment-Based Design of Ligands Targeting a Novel Site on the Integrase Enzyme of Human Immunodeficiency Virus1. / Wielens, J; Headey, S J; Deadman, J J; Rhodes, D I; Parker, M W; Chalmers, D K; Scanlon, M J.

In: ChemMedChem, Vol. 6, No. 4, 04.04.2011, p. 583.

Research output: Contribution to journalComment / DebateOtherpeer-review

TY - JOUR

T1 - Corrigendum

T2 - Fragment-Based Design of Ligands Targeting a Novel Site on the Integrase Enzyme of Human Immunodeficiency Virus1

AU - Wielens, J

AU - Headey, S J

AU - Deadman, J J

AU - Rhodes, D I

AU - Parker, M W

AU - Chalmers, D K

AU - Scanlon, M J

PY - 2011/4/4

Y1 - 2011/4/4

KW - Antiviral agents

KW - Fragment-based drug design

KW - HIV-1 integrase

KW - NMR spectroscopy

UR - http://www.scopus.com/inward/record.url?scp=79953047310&partnerID=8YFLogxK

U2 - 10.1002/cmdc.201190013

DO - 10.1002/cmdc.201190013

M3 - Comment / Debate

VL - 6

SP - 583

JO - ChemMedChem

JF - ChemMedChem

SN - 1860-7179

IS - 4

ER -